Elsevier

International Journal of Cardiology

Volume 221, 15 October 2016, Pages 134-140
International Journal of Cardiology

Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease,☆☆

https://doi.org/10.1016/j.ijcard.2016.06.181Get rights and content

Abstract

Background

Increasing evidence indicated that phosphorus emerged as an important cardiovascular risk factor in patients with chronic kidney disease (CKD). The fact that serum phosphorus was closely linked to vascular and valvar calcification may account for one important reason. However, left ventricular remodeling may also serve as another potential mechanism of the cardiac toxicity of phosphorus. In the present study, we evaluated the association of serum phosphorus with left ventricular remodeling.

Methods

We investigated consecutive hospitalized patients with pre-dialysis CKD, who did not have symptomatic heart failure or take any phosphorus binder or calcitriol medications. Transthoracic echocardiography was applied to assess their left ventricular remodeling indices, both structural and functional.

Results

The 296 study subjects (mean age 56.4 years) included 169 (57.1%) men, 203 (68.6%) hypertensive patients. In addition to gender, systolic blood pressure, and estimated glomerular filtration rate, serum phosphorus was an independent determinant of left ventricular mass index (LVMI, P = 0.001). Similarly, serum phosphorus was also a determinant of left ventricular end diastolic dimension (P = 0.0003), but not of relative wall thickness. In multivariate logistic analyses, serum phosphorus was significantly and independently associated with the prevalence of left ventricular hypertrophy (LVH, odds ratio [OR] 2.38 for each 1 mmol/L increase, 95% CI 1.20–4.75, P = 0.01). Moreover, the association was only confirmatory in eccentric LVH (OR 3.01, 95% CI 1.43–6.32, P = 0.003) but not in concentric LVH (1.38, 95% CI, 0.54–3.49, P = 0.50).

Conclusion

Serum phosphorus was significantly and independently associated with LVMI and the prevalence of eccentric LVH in hospitalized patients with CKD.

Introduction

It is well established that chronic kidney disease (CKD) carries a high public health burden and cardiovascular diseases (CVD) are the leading causes of death in CKD [1], [2]. Indeed, mildly to moderately impaired renal function can convey a high risk of CVD [3]. Even CKD patients are more likely to die of CVD before they reach end stage renal disease [3]. Cardiac structural and functional changes are the most prevalent cardiovascular risks in CKD, accounting for a large number of cardiovascular mortality [4], [5]. Cardiac structural and functional changes start in the early stages of CKD and this association strengthens in patients with deteriorated renal function approaching or on dialysis [6], [7]. These cardiac changes observed in CKD patients are attributed to not only conventional risk factors but also CKD-related risk factors such as uremic toxins, anemia, mineral metabolism disorders and so on [8].

Recently, serum phosphorus emerged as an important cardiovascular risk factor. Increased serum phosphorus, which is prevalent in CKD patients due to impaired phosphorus excretion, was associated with adverse cardiovascular outcomes in both maintenance hemodialysis [9] and earlier stages of CKD patients [10]. Even serum phosphorus in normal range has been linked with cardiovascular events in coronary disease [11], type 2 diabetes [12], or the incidence of CVD in the community [13], [14]. However, the underlying mechanism between phosphorus and CVD has not yet been clarified.

Left ventricular remodeling may be the structural basis of heart failure, arrhythmias and sudden cardiac death, which are the most common causes of cardiac death [15]. Although blood pressure still plays a major role in the process inducing left ventricular remodeling in CKD, some other CKD-related factors may also be actively involved in the process. The fact that serum phosphorus is closely linked to vascular and valvar calcification may account for one important reason [16]. However, left ventricular remodeling may also serve as another potential mechanism of the cardiac toxicity of phosphorus. Some studies indicated the significant association between serum phosphorus and left ventricular mass in community-based population [17], [18], male stable CVD outpatients [19], and CKD outpatients [20]. However, few studies have characterized the association of serum phosphorus with left ventricular geometry remodeling.

In the present study, we conducted a cross-sectional analysis between serum phosphorus and left ventricular remodeling among hospitalized patients with pre-dialysis CKD, who did not have symptomatic heart failure or take phosphorus binders or calcitriol medications. We characterized the associations of serum phosphorus with left ventricular mass and morphology. Since CKD is closely associated with hypertension and left ventricular remodeling is a well recognized consequence of hypertension, we explored blood pressure and renal function in relation to left ventricular remodeling as compared to serum phosphorus.

Section snippets

Study Population

From January to December 2014, we studied 405 consecutive patients with chronic kidney disease, who were hospitalized in the Department of Nephrology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine in Shanghai, China. We excluded 109 subjects from the present analysis, because of severe systolic dysfunction with left ventricular ejection fraction less than 50% (n = 19), moderate to severe cardiac valve diseases (n = 17), or taking phosphate binders or calcitriol

Characteristics of the Study Subjects

The 296 study subjects (mean age 56.4 years) included 169 (57.1%) men, 203 (68.6%) hypertensive patients, of whom 171 (58%) took antihypertensive drugs, and 64 (21.6%) diabetic patients. Table 1 shows the characteristics of the study subjects categoried by serum phosphorus in tertiles. Blood pressure and iPTH significantly increased, while serum corrected calcium, hemoglobin, and renal function decreased across increasing tertiles of serum phosphorus (P  0.002). Among echocardiographic indices,

Discussion

In this study, we found that serum phosphorus was significantly and independently associated with LVMI and the prevalence of LVH in hospitalized patients with CKD. To the best of our knowledge, our study was the first to demonstrate this association mainly due to the eccentric left ventricular remodeling. As compared, both SBP and eGFR were associated with LVMI and the prevalence of LVH, with SBP associated with both concentric and eccentric LVH, whereas eGFR, excluded the effect of serum

Conflicts of interest

The authors report no relationships that could be construed as a conflict of interest.

Acknowledgments

The authors gratefully acknowledge the voluntary participation of all study subjects.

References (40)

  • A.S. Go et al.

    Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

    N. Engl. J. Med.

    (2004)
  • A. Kottgen et al.

    Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study

    J. Am. Soc. Nephrol.

    (2007)
  • C. Zoccali

    How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease

    Nat. Clin. Pract. Nephrol.

    (2007)
  • M. Park et al.

    Associations between kidney function and subclinical cardiac abnormalities in CKD

    J. Am. Soc. Nephrol.

    (2012)
  • C.D. Chue et al.

    Arterial stiffness in chronic kidney disease: causes and consequences

    Heart

    (2010)
  • G.A. Block et al.

    Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

    J. Am. Soc. Nephrol.

    (2004)
  • H. Eddington et al.

    Serum phosphate and mortality in patients with chronic kidney disease

    Clin. J. Am. Soc. Nephrol.

    (2010)
  • M. Tonelli et al.

    Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

    Circulation

    (2005)
  • R. Dhingra et al.

    Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community

    Arch. Intern. Med.

    (2007)
  • M. Tonelli et al.

    Chronic kidney disease and mortality risk: a systematic review

    J. Am. Soc. Nephrol.

    (2006)
  • Cited by (19)

    • Phosphate Balance and CKD–Mineral Bone Disease

      2021, Kidney International Reports
      Citation Excerpt :

      It is estimated that patients with poorly managed phosphate have almost 30% greater mortality risk than those who consistently achieve and maintain normal phosphate concentrations.75 Approximately 70% of patients on dialysis have left ventricular hypertrophy, a known risk factor for CVD and mortality that is strongly associated with higher phosphate concentrations.76–78 Additionally, hyperphosphatemia is directly linked to hypertension, a major CVD risk factor that is seen in up to 90% of patients with CKD.79

    • Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis

      2020, Journal of Cardiac Failure
      Citation Excerpt :

      The lack of association between phosphate clearance and LVH in this study is perhaps unsurprising, given that the relationship between disordered mineral metabolism and LVH is unclear. Phosphate has been associated with LVH in nondialysis chronic kidney disease.18 In recipients of hemodialysis, the calcium × phosphate product may associate with LVH, but phosphate, calcium and parathyroid hormone do not appear to do so independently.19

    • Association of serum calcium and phosphorus with measures of left ventricular structure and function: The ARIC study

      2020, Nutrition, Metabolism and Cardiovascular Diseases
      Citation Excerpt :

      Notably, the association between serum phosphorus and hypertrophy was only present in the ARIC participants with preserved EF, and those without prevalent CHD. Although a prior study of chronic kidney disease patients found that serum phosphorus was significantly associated with eccentric LVH [42], in our sample there was no association of serum phosphorus with LV geometry. This study has some limitations that need to be considered.

    • Resistin as a predictor of cardiovascular hospital admissions and renal deterioration in diabetic patients with chronic kidney disease

      2019, Journal of Diabetes and its Complications
      Citation Excerpt :

      Phosphorous has been associated with left ventricular hypertrophy (LVH), but the literature lacks studies without confounding factors.36 Nevertheless, a recent study demonstrated that phosphorous was not only individually implicated in ventricular hypertrophy, but also in cardiovascular hospital admissions in patients with CKD.37 PTH has also been associated to LVH in recent studies, however the results are also susceptible to confounding factors.38,39

    • Renal denervation in patients with chronic kidney disease

      2017, International Journal of Cardiology
    • FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

      2019, Nefrologia
      Citation Excerpt :

      Hyperphosphatemia can itself cause vascular deposition of calcium phosphate, but more importantly causes a phenotypic conversion of smooth muscle cells to osteoblasts.46 Plasma phosphate is positively correlated with LVH.47–49 LVH and increased myocardial fibrosis is primarily caused by hypertension, chronic secondary hyperaldosteronism and damage by unidentified uremic toxins.

    View all citing articles on Scopus

    These authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

    ☆☆

    Acknowledgement of grant support: The present study was financially supported by grants from Shanghai Jiao Tong University School of Medicine (14XJ10032).

    View full text